[HTML][HTML] Human epidermal growth factor receptor 2 (HER2)–specific chimeric antigen receptor–modified T cells for the immunotherapy of HER2-positive sarcoma
Journal of clinical oncology, 2015•ncbi.nlm.nih.gov
Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified
T Cells for the Immunotherapy of HER2-Positive Sarcoma - PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main
Navigation Search PMC Full-Text Archive Search in PMC Advanced Search User Guide
Journal List J Clin Oncol PMC4429176 Other Formats PDF (1.3M) Actions Cite Collections
Share Permalink Copy RESOURCES Similar articles Cited by other articles Links to NCBI …
T Cells for the Immunotherapy of HER2-Positive Sarcoma - PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main
Navigation Search PMC Full-Text Archive Search in PMC Advanced Search User Guide
Journal List J Clin Oncol PMC4429176 Other Formats PDF (1.3M) Actions Cite Collections
Share Permalink Copy RESOURCES Similar articles Cited by other articles Links to NCBI …
Abstract
Purpose
The outcome for patients with metastatic or recurrent sarcoma remains poor. Adoptive therapy with tumor-directed T cells is an attractive therapeutic option but has never been evaluated in sarcoma.
ncbi.nlm.nih.gov